$128.33
▲ $0.33 (+0.3%)
MRK
Merck & Co.
Health Care
Investor Score
62C+
Moderate rating
Based on 7 of 7 weighted categories, computed from real, live financial data only.
69
Technical
74
Fundamental
50
Growth
38
Fair Value
86
News
50
Quality
56
Risk
Want the full breakdown — DCF fair value, technical indicators, news sentiment, and an AI-written narrative explaining this score?
View the full analysis (Hebrew) ←All raw data comes from real commercial financial data providers. This page is for educational purposes only and is not investment advice.